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Metagenomics seeks to characterize the composition of microbial communities, their operations, 
and their dynamically coevolving relationships with the habitats they occupy without having to 
culture community members. Uniting metagenomics with analyses of the products of microbial 
community metabolism (metabolomics) will shed light on how microbial communities function in a 
variety of environments, including the human body.Metagenomics is a rapidly grow-
ing area of the genome sciences that 
seeks to define the features of intact 
microbial communities in their native 
habitats (Box 1). It allows us to see, 
with a new and powerful set of lenses, 
the vast microbial and metabolic diver-
sity that exists in our biosphere. The 
scale of this diversity is mind-boggling. 
The estimated total number of micro-
bial cells is 1030: these microbes may 
harbor as many as 1031 phage (Din-
sdale et al., 2008). Their genomes 
encode a wide variety of enzymes that 
influence major metabolic fluxes within 
the biosphere, from phototrophy in the 
sea (DeLong et al., 2006; Frias-Lopez 
et al., 2008), to phosphate removal in 
industrial sludge (Martin et al., 2006), 
to nutrient harvest from the diet in ani-
mal guts (Gill et al., 2006; Turnbaugh et 
al., 2006, 2008; Warnecke et al., 2007). 
Metagenomics provides us with an 
unprecedented opportunity to assess 
the metabolic features of microbial 
communities without the need to cul-
ture their component members. The 
results promise to impact a wide range 
of “bio”-related disciplines, including 
biomedicine, bioenergy, bioremedia-
tion, and biodefense (Committee on 
Metagenomics, 2007).
Metagenomics creates experimental, 
computational, and conceptual connec-
tions between the too-often artificially 
separated worlds of environmental and 
medical microbiology. For example, 
although our development occurs in the 
apparently microbe-free environment 
of the uterus, beginning at birth we are 
colonized by members of all three known 
domains of life: Bacteria, Archaea, and 
Eukarya. As adults, the number of 
microbial cells associated with our adult 
human bodies likely exceeds the number 
of our somatic and germ cells by 10-fold. 
Studies of model organisms suggest 
that acquisition of this microbiota (Box 1) 
reflects a combination of legacy effects 
(a summation of the microbes we are 
exposed to in our distinctively experi-
enced living environments) and habitat 
effects (largely ill-defined “filters” that 
operate to select microbes for residency 
in our different body sites) (Rawls et al., 
2006).
In many ways, we should view our-
selves, and all other animals, as “supraor-
ganisms,” composed of mixtures of host 
and microbial cells, genes, and meta-
bolic attributes. Defining the gene con-
tent of our microbiota (the “microbiome”) 
represents a first step in exploring the 
largely mysterious biotransformations 
that are supported by its constituents. 
The metabolome—the metabolites gen-
erated by one or more organisms under 
a particular set of physiological/environ-
mental conditions (Box 1)—holds the key 
to moving beyond descriptions of the 
composition of our indigenous micro-
bial communities (that is, their compo-
nent organisms, genes, transcripts, and 
proteins). The metabolome will enable 
a better understanding of the dynamic 
operations of our indigenous microbial 
communities and their functional contri-
butions to the various body habitats that 
they occupy. These contributions include 
metabolic activities that are not encoded 
in our human genome, for example, the 
breakdown of otherwise difficult to digest 
plant glycans, synthesis of vitamins, and 
the processing of various xenobiotics 
that we consume (either intentionally or 
unintentionally).
Metagenomics: Three Reasons  
to Care
The skeptical reader may suppose that 
metagenomics is currently just a limited 
set of evolving DNA-centric experimental 
and computational techniques, driven in 
large part by the introduction of massively 
parallel sequencers that, unlike capillary 
machines, do not require subcloning of 
DNA fragments prior to sequencing. Our 
retort is a “yes but”…there are at least 
three reasons why data generated by the 
sequencing of microbial community DNA, 
including 16S rRNA genes, will be neces-
sary to understand microbial metabolism 
and therefore community function. First, 
only a small fraction of microbial diver-
sity in the biosphere can be isolated in 
pure culture, presumably because of 
the highly artificial and limited number 
of conditions used currently for cultiva-
tion. This problem has been called the 
“great plate-count anomaly” and refers 
to the fact that the number of organisms 
cultured from a community is typically 
far less than the number observed using 
culture-independent methods such as 
16S rRNA gene sequencing (e.g., Huber 
et al., 2007; Roesch et al., 2007). In addi-
tion, culture-based approaches do not 
scale as readily as culture-independent 
techniques: for example, a single mas-
sively parallel pyrosequencer can gen-708 Cell 134, September 5, 2008 ©2008 Elsevier Inc.
erate more than 2 million sequencing 
reads from 16S rRNA genes each day—a 
number well beyond the range of our 
current capacity for culturing microor-
ganisms. Second, multiple representa-
tives of the same “species” (commonly 
defined as organisms that share ≥97% 
nucleotide sequence identity between 
their 16S rRNA genes) can have a sur-
prising amount of variability in their pro-
teomes. For example, comparisons of 32 
Escherichia coli and Shigella genomes 
(Willenbrock et al., 2007) and an analy-
sis of six strains of Streptococcus aga-
lactiae (Tettelin et al., 2005) disclosed 
a large set of seemingly “dispensable” 
genes found in subsets of the genomes 
from each “species.” Such observa-
tions indicate that a future definition of 
species will be gleaned from analyses 
of the functions encoded by the shared 
(core) set of genes present in a larger 
“pan-genome” that represents the sum 
of all genes found in all isolates of a 16S 
rRNA-defined species-level phylotype 
(Box 1). The bottom line is that the total 
number of genome variants in a commu-
nity is likely to greatly exceed the number 
of 16S rRNA-based phylotypes. Metag-
enomic sequencing of total community 
DNA offers a rapid and efficient way of 
addressing these issues whether or not 
the microbes can be cultured. Third, most 
microbial metabolic processes in nature 
occur in the context of communities, not 
pure cultures. There are clearly many 
advantages to exploring the niche (pro-
fessions) of organisms in pure cultures, 
including the opportunity for controlled 
experimentation. However, metagenom-
ics represents a conceptual framework 
for analyzing microbial metabolism at a 
higher level of organization than that of 
a single organism. Metagenomic studies 
of microbial communities are revealing 
how many emergent properties become 
apparent in the context of a complex 
system that could not be easily deduced 
from an analysis limited to its individual 
components. For example, the global 
distribution of the dominant Cyanobac-
teria, Prochlorococcus, in large regions 
of the world’s oceans could be inferred 
through computational analyses of a 
model marine ecosystem seeded with 
diverse phytoplankton having randomly 
assigned physiological characteristics 
(Follows et al., 2007).Metagenomics for Predicting 
Microbial (and Host) Metabolism
Metagenomics has already proven use-
ful in going from DNA sequence data 
to understanding the metabolism of 
relatively “simple” microbial communi-
ties. An excellent example is the shot-
gun sequencing of DNA isolated from a 
low-complexity microbial biofilm com-
munity that forms in the acidic water, 
rich in pyrite (FeS2), that drains from an 
abandoned mine in Iron Mountain, Cali-
fornia (Tyson et al., 2004). This approach 
allowed the genomes of two previously 
uncultured organisms, Leptospirillum 
group II and Ferroplasma type II, to be 
assembled into a relatively small number 
of contigs. The deep sequence cover-
age achieved was used to surmise that 
the Ferroplasma type II genome was 
actually a composite of three ancestral 
strains that have undergone extensive 
homologous recombination, producing a 
population of mosaic genomes. The Lep-
tospirillum group II and the less abundant 
group III genomes encode key enzymes 
in the Calvin-Benson-Bassham cycle for 
carbon fixation (type II ribulose 1,5-bis-Cell 134, phosphate carboxylase-oxygenase). The 
Ferroplasma type II genome assembly 
contains multiple ABC-type sugar and 
amino acid transporters indicative of a 
heterotrophic lifestyle in which organic 
matter is used for energy (Tyson et al., 
2004). Furthermore, the Leptospirillum 
group III genome assembly has a single 
nitrogen fixation operon (nif ), suggesting 
a role for these low abundance bacte-
ria as the primary nitrogen fixers in the 
acid mine community. These in silico 
predictions were subsequently validated 
experimentally (Tyson et al., 2005).
Another example is the shotgun 
sequencing of DNA prepared from two 
relatively low-complexity communities 
that had been seeded in the laboratory 
from a man-made industrial sludge. 
This sludge has ecological importance 
because of its capacity for microbe-
mediated removal of inorganic phos-
phate from the environment. The results 
allowed the genome of the dominant but 
previously uncultured member, Candi-
datus Accumulibacter phosphatis, to be 
assembled. In silico metabolic recon-
structions revealed how the organism Box 1. Glossary
Metagenomics: An emerging field encompassing culture-independent studies of the struc-
tures and functions of microbial communities and their interactions with the habitats they 
occupy. Metagenomics includes (1) shotgun sequencing of microbial DNA isolated directly 
from a given environment, (2) high-throughput screening of expression libraries, constructed 
from cloned community DNA, to identify specific functions such as antibiotic resistance 
(functional metagenomics), (3) profiling of RNAs and proteins produced by a microbiome 
(meta-transcriptomics and meta-proteomics), and (4) identification of a community’s 
 metabolic network (meta-metabolomics). 
Metabolomics: The characterization by mass spectroscopy, NMR, or other analytical 
methods of metabolites generated by one or more organisms in a given physiological and 
environmental context. 
Microbiota: A microbial community, including Bacteria, Archaea, Eukarya, and viruses, that 
occupies a given habitat. 
Microbiome: In ecology, the term “biome” refers to a habitat and the organisms in it. In this 
sense, the human “micro”biome would be defined as the collection of microorganisms as-
sociated with the human body, and their collective genomes would constitute a metagenome. 
However, the term microbiome is now commonly used to refer to the collective genomes pres-
ent in members of a given microbiota. 
Phylotype: A phylogenetic group of microbes, currently defined by a threshold percent identity 
shared among their small subunit (16S) rRNA genes (e.g., ≥97% for a “species” level phylotype). 
Pan-genome: The group of genes found in genomes comprising a given phylotype. This 
includes “core” genes found in all genomes and “dispensable” genes found in a subset of 
genomes within the phylotype. 
Core human microbiome: Whatever is shared in a given body habitat among all or the vast 
majority of human microbiomes. A core microbiome may include a common set of organisms 
(genomes), gene or protein families, and/or metabolic capabilities. Microbial genes that are 
variably represented in different humans may contribute to our distinctive metabolic attributes 
(metabotypes). 
Seed bank: Low-abundance phylotypes within a microbiota that may not significantly alter 
major metabolic fluxes. These phylotypes can include transient (allochthonous) members of 
the community. 
Gene bank: Low-abundance genes found within a given microbiome or pan-genome. Some 
of these genes may be the result of lateral gene transfer from allochthonous organisms and 
may include unique metabolic activities found in members of the seed bank.September 5, 2008 ©2008 Elsevier Inc. 709
may (1) dispose of inorganic phosphate 
(through import and metabolism to 
polyphosphate, which is then used to 
provide energy for importing and stor-
ing fatty acids), (2) degrade glycogen 
(through the Embden-Meyerhof but not 
the Entner-Doudoroff pathway), and (3) 
produce NADPH via a novel cytochrome 
b/b6 (Martin et al., 2006).
Metagenomic approaches have also 
been used to investigate the metabolic 
underpinnings of host-bacterial symbio-
ses in invertebrates. Olavius algarven-
sis, a marine worm that lacks a mouth, 
gut, or anus, harbors four known Pro-
teobacterial symbionts below its cuticle 
(Woyke et al., 2006). Shotgun sequenc-
ing of microbial community DNA, and in 
silico reconstructions of the metabolic 
pathways encoded by the microbiome 
of this gutless worm, revealed that its 
symbionts—including a sulfate-reducing 
δ-Proteobacteria and a sulfur-oxidiz-
ing chemoautotroph belonging to the 
γ-Proteobacteria—have important meta-
bolic capabilities. They are able to pro-
vide the host with nutrients (amino acids 
and vitamins) derived from reduced 
sulfur compounds, hydrogen, CO2, or 
dissolved organic carbon from the envi-
ronment, and to remove metabolic end-
products generated by the worm (ammo-
nium, urea, and short-chain fatty acids).
Likewise, DNA-level metagenomic 
analysis of the Sharpshooter, a major 
agricultural pest that feeds on the xylem 
fluid of plants and acts as a vector for 
plant pathogens, disclosed that one of 
its symbionts, the γ-Proteobacteria Bau-
mannia cicadellinicola, has the capacity 
to provide it with vitamins [thiamine (B1), 
riboflavin (B2), niacin (B3), panthothenic 
acid (B5), pyridoxine (B6), biotin, and folic 
acid]. Another one of its symbionts, Sul-
cia muelleri (a Bacteroidetes), has the 
capacity to supply the Sharpshooter with 
amino acids (threonine, leucine, valine, 
isoleucine and potentially lysine, argin-
ine, and tryptophan) (Wu et al., 2006).
A recent study of obligate γ-Proteo-
bacterial symbionts that live in the poste-
rior midgut of the stinkbug demonstrated 
that pest behavior (fitness on crop 
legumes) is dependent on this microbe. 
When symbiont strains, with 99.9% 
identical 16S rRNA gene sequences, 
are experimentally exchanged between 
a stinkbug pest species (Megacopta 
punctatissima) and a non-pest species 
(Megacopta cribraria), the pest pheno-
type is reversed (Hosokawa et al., 2007). 
Sequencing of these uncultured symbi-
ont genomes will likely reveal candidate 
pest-promoting microbial genetic deter-
minants.
Metagenomics has also identified dis-
tinguishing metabolic features of very 
complex microbial communities, includ-
ing those associated with an agricultural 
soil, sunken whale carcasses (whale 
falls), and the ocean (Tringe et al., 2005). 
Comparisons of the soil and Sargasso 
Sea microbiomes showed an enrichment 
(significantly higher relative abundance) 
of genes involved in degradation of 
plant material in the soil (e.g., predicted 
genes encoding cellobiose phospho-
rylase) and enrichment for light-driven 
proton pumps (bacteriorhodopsins) in 
the Sargasso Sea (Tringe et al., 2005). 
Furthermore, the ocean is composed of 
stratified microbial assemblages: stud-
ies of microbiome gene content at mul-
tiple depths (10 m–4000 m) identified 
differences in the relative abundance of 
specific categories of genes. The more 
productive photic zone community has 
a higher relative abundance of photo-
synthesis genes than the deep water 
community, a lower representation of 
genes indicative of lateral gene trans-
fer (transposases), and a higher relative 
abundance of cyanophage (DeLong et 
al., 2006).
Metagenomic studies of complex 
communities are also linking micro-
biomes to mechanisms underlying 
biomass conversion in a variety of 
biological bioreactors, including the 
mouse and human intestine (Turn-
baugh et al., 2006, 2008; Gill et al., 
2006; Kurokawa et al., 2007). Surveys 
of 16S rRNA sequences present in the 
distal gut microbiota of lean and obese 
mice and humans revealed an associa-
tion between adiposity and the relative 
proportions of the two dominant bacte-
rial divisions in these mammalian eco-
systems—the Bacteroidetes and the 
Firmicutes (Ley et al., 2006). Sequenc-
ing DNA isolated from the distal intes-
tines of genetically obese (ob/ob) mice 
and their lean (ob/+, +/+) littermates 
disclosed a significant enrichment for 
genes in the ob/ob gut microbiome that 
are involved in harvesting energy from 
polysaccharides. These in silico meta-
bolic predictions were supported by 
biochemical analyses, and by micro-
biome transplantation experiments. 
The latter involved transfer of unfrac-
tionated distal gut microbial communi-
ties from ob/ob and lean (+/+) donors to 
wild-type germ-free mouse recipients. 
The obese mouse gut community pro-
duced a significantly greater increase 
in adiposity in recipients over a 2 week 
period (Turnbaugh et al., 2006).
Follow-up studies of a mouse model 
of diet-induced obesity caused by 
consumption of a high-fat, high-sugar 
“Western” diet revealed that obesity was 
associated with marked but reversible 
structural and functional changes in the 
gut microbiome. In particular, there was 
a bloom in a single uncultured clade of 
bacteria within the Mollicutes class of 
the Firmicutes division and an increased 
ability of this community to promote adi-
posity in germ-free recipients compared 
to recipients of a microbiota harvested 
from lean mice consuming a standard 
chow diet. Metagenomic sequencing of 
the gut microbiome, biochemical assays, 
plus sequencing, and in silico metabolic 
reconstructions of a related human gut-
associated Mollicute (Eubacterium doli-
chum) revealed features that may provide 
a competitive advantage for members 
of the bloom in the Western diet nutri-
ent milieu, including genes involved in 
import and metabolism of simple sugars 
(Turnbaugh et al., 2008).
An initial analysis of the fecal micro-
biomes of two unrelated humans (Gill 
et al., 2006) showed that compared 
to all previously sequenced microbial 
genomes and the human genome, the 
human gut microbiome is enriched for 
genes involved in a number of metabolic 
pathways. These genes include those 
for (1) 2-methyl-D-erythritol 4-phos-
phate pathway-mediated biosynthesis 
of essential vitamins (e.g., thiamine and 
pyridoxine) and isoprenoids (derivatives 
of isopentenyl pyrophosphate), (2) the 
metabolism of amino acids, xenobiot-
ics (including carcinogens), and dietary 
polysaccharides, and (3) methanogen-
esis. Methanogenesis is a key metabolic 
pathway, present in members of the 
Euryarchaeota division of Archaea, that 
removes the H2 end-product of bacterial 
fermentation of dietary polysaccharides, 710 Cell 134, September 5, 2008 ©2008 Elsevier Inc.
thereby preventing inhibition 
of this process. Inhibition 
occurs because the flux of 
sugars through the glycolytic 
pathway leads to accumula-
tion of NADH. Removal of 
hydrogen by methanogenic 
Archaea, by phylogenetically 
diverse acetogens that use 
the Wood-Ljungdhal path-
way for synthesis of acetyl-
CoA from CO2, and/or by 
Proteobacteria that reduce 
sulfate to sulfide (a genotoxic 
compound) allows NADH to 
be oxidized to NAD+ (Drake et 
al., 2006).
These metagenomic anal-
yses were subsequently ex-
tended to the fecal micro-
biomes of 13 healthy humans, 
including 4 suckling infants, 2 
children, and 7 adults (Kuroka-
wa et al., 2007). Comparative 
metagenomics revealed that 
the infant fecal microbiome 
is highly variable, consistent 
with a recent 16S rRNA gene 
sequence-based study of mi-
crobial community assembly 
in the gut of infants during the 
first year after birth (Palmer et 
al., 2007). In silico functional 
analyses of the adult human 
fecal microbiome versus pre-
viously sequenced microbial 
genomes confirmed that it is 
enriched for genes involved 
in carbohydrate and amino 
acid metabolism, including a 
number of polysaccharide-
degrading glycoside hydrolases. Ad-
ditionally, the human gut microbiome 
contains many conjugative transposon 
sequences, emphasizing the potential 
role of lateral gene transfer in shaping 
gut genomes (Kurokawa et al., 2007).
One notion that can be abstracted 
from these studies of mammalian gut 
microbiomes is that the nutrient/ener-
getic value of food is a relative, not an 
absolute term that can be influenced 
by metabolic activities encoded in the 
microbiome. In turn, our food choices 
may become imprinted into our supraor-
ganismal metabolome in part by affect-
ing the structure and activity of the gut 
microbiota (Rezzi et al., 2007; also see 
the Forum by Holmes et al., page 714 
of this issue). This metabolic imprinting 
could be initiated at an early stage of 
life. It follows that metagenomic stud-
ies should allow us to obtain a deeper 
understanding of the nutritional needs 
of humans. The results could yield 
microbiome-based biomarkers for 
identifying those at risk for obesity or 
malnutrition, dietary recommenda-
tions based on the nutrient-process-
ing capacities of the gut microbiota 
of various human populations, and a 
new understanding about why certain 
prevention strategies and therapeutic 
interventions fail in some but succeed 
in others (Prentice et al., 2008).
Biodiversity and the 
Global  Dispersal of 
Microbiomes
An issue facing the mar-
riage of metagenomics and 
metabolomics relates to the 
global dispersal of microbes. 
Some have proposed that 
microbes are not geographi-
cally isolated, given a gener-
ally large population size of 
each microbial phylotype in 
the biosphere and presumed 
minimal barriers to global dis-
persal. This would mean that 
in many environments there 
are members of all or the 
vast majority of phylotypes, 
and the habitat (continuously) 
selects to determine relative 
abundance. This conceptual 
framework can be depicted 
in a rank abundance plot of 
diversity (Figure 1). In this 
plot, the highly abundant phy-
lotypes are viewed as respon-
sible for most active growth 
and carbon and energy flux 
in a given ecosystem, with 
the rare phylotypes forming 
a “seed bank” (a term defined 
here as a set of organisms 
present at low abundance 
that may or may not signifi-
cantly alter major metabolic 
fluxes) (Pedros-Alio, 2006; 
Box 1).
If this formulation were 
extended to microbiomes, it 
would suggest that if the vast 
majority of phylotypes are 
present in a given environment, then most 
microbial genes might also be present in 
that environment. This does not appear 
to be the case in low-complexity micro-
bial communities (e.g., the acid mine 
drainage) or in certain host-symbiont 
relationships (e.g., the Sharpshooter, the 
gutless worm, and the light organ of the 
squid Euprymna scolopes, which is col-
onized by a single dominant bacterium, 
Vibrio fischeri). However, it may be true 
for environments with potentially less 
restricted barriers to colonization, such 
as the ocean, soil, or even the human ali-
mentary tract (Hooper et al., 2008). Fur-
thermore, given the extent of lateral gene 
transfer in environments such as the 
Figure 1. Common and Rare Components of the Microbiome
A theoretical framework for the global dispersal of phylotypes (defined by per-
cent identity of 16S rRNA genes) and gene families (defined through homol-
ogy, Hidden Markov Models of protein domains, and/or enzymatic activity). 
(A) The graph depicts a rank-abundance plot of the phylotypes or gene fami-
lies present in a given habitat (e.g., ocean, soil, or gut); phylotypes or gene 
families are plotted in decreasing abundance across the x axis. The orange 
portion of the curve can be defined as the portion of the community undergo-
ing active growth and the abundant gene families that are primarily respon-
sible for the major metabolic fluxes within a given habitat. The red portion of 
the curve comprises the seed/gene bank. The seed/gene bank represents 
the low-abundance members that may or may not significantly alter features 
of community metabolism depending upon the environmental context (the 
seed bank) and the rare genes that may be found in a small subset of ge-
nomes within a given phylotype (dispensable genes), or in the genomes of 
rare (including transient or allochthonous) members of the community (the 
gene bank). 
(B) This distribution can be altered in a different habitat, or in the same habitat 
after perturbation by disease or a change in available nutrients.Cell 134, September 5, 2008 ©2008 Elsevier Inc. 711
distal human intestine, where microbial 
densities approach 1012 organisms per 
milliliter of gut luminal contents (Xu et al., 
2007), plus the results of initial studies of 
bacterial pan-genomes, it seems likely 
that a large number of rare genes may 
be found in members of a wide variety of 
phylotypes.
This point becomes important when 
considering how microbial communi-
ties adjust their metabolic activities to 
changing environmental conditions, 
and how to define a “core microbiome.” 
The core human microbiome has been 
viewed as whatever is shared in a given 
body habitat among the vast majority of 
human microbiomes (e.g., Turnbaugh 
et al., 2007). Relative abundance needs 
to be factored into this definition of a 
core microbiome: the “gene bank” will 
likely contain a large number of genes 
that are present at incredibly low rela-
tive abundance in all human-associated 
communities and are thus extremely dif-
ficult to detect (Figure 1A). A more read-
ily defined facet of the core microbiome 
could be the set of abundant genes that 
influence major metabolic cycles. The 
more elusive gene bank would include a 
vast assortment of rare genes that may 
not markedly affect carbon, nitrogen, or 
other nutrient and energy fluxes within 
a microbial community, and between 
a microbiota and its host. Nonethe-
less such a gene bank could contribute 
other important features to community 
and host metabotypes, and to the resil-
iency of a microbial community when its 
structure is perturbed (Figure 1B). How-
ever, many of these rare microbial genes 
may not encode functions that confer a 
detectable selective advantage to the 
host under various circumstances.
The Human Microbiome Project and 
Metabolomics
Human microbiome projects are being 
launched that will survey microbiomes 
in a number of body habitats of people 
of varying ages and genotypes, living 
in different ecosystems, in societies 
with varying lifestyles (Turnbaugh et al., 
2007). As these efforts seek to discover 
connections between our supraorganis-
mal metabolism and our microbial ecol-
ogy, they will have to address a number 
of the questions alluded to above. For 
example, what is the underlying popu-
lation structure of the microbial com-
munities that occupy our various body 
habitats at various time points over a 
life span? What is the provenance of the 
organismal lineages that comprise these 
communities: how much vertical trans-
mission is there from our mothers and/
or other family members? How much 
functional redundancy exists between 
the myriad bacterial strains that com-
prise our microbiota, and between com-
munities whose diversity has only been 
described in terms of 16S rRNA-based 
phylogenies? How can we improve pre-
dictions about the metabolic capabilities 
and activities of a microbial commu-
nity from metagenomic data? The lat-
ter question embraces issues of how 
to generate more reliable predictions 
of gene function, how to create better 
algorithms for identifying protein families 
and metabolic pathways (Godzik et al., 
2007; Yooseph et al., 2007), and how to 
integrate metabolite data from NMR and 
mass spectrometry with DNA, mRNA, 
and protein data sets.
The task of answering these questions 
is daunting and the outcomes uncer-
tain. We believe that addressing many of 
these questions will require concomitant 
metagenomic studies of genetically mal-
leable model host organisms with defined 
genotypes, raised under germ-free con-
ditions, that are then colonized at vary-
ing times during their life with defined 
consortia of sequenced microbial phy-
lotypes (a “type community” much as 
there are “type strains”). These gnotobi-
otic models should allow general princi-
ples to be gleaned about the coevolution 
and interoperability of microbial and host 
metabolomes, as many of the confound-
ing variables that apply to humans (diet, 
genotype, environmental exposures) can 
be constrained. Much will be learned 
from careful energy and nutrient balance 
studies of these gnotobiotic animals, 
from characterization of host and micro-
bial community genomes, transcrip-
tomes, proteomes, and metabolomes, 
and from identifying microbiome-based 
biomarkers of metabolic activities. This 
knowledge can then be tested in humans 
with the goal of achieving more compre-
hensive phenotyping of our physiology, 
more accurate definitions of our health, 
more insightful stratification of our risks 
for various metabolic disorders, and new 
ways for intentionally manipulating our 
microbiomes to optimize their functions 
in the context of our individual biological 
milieus.
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